Similar data were also obtained in the SCAN-B cohort (Figure 4F, p = 0.0001, and Table S1A), despite no correlation with survival in this cohort, as mentioned earlier, suggesting LCN2 expression is elevated in more aggressive types of breast cancers. Here, LCN2 is linked to breast carcinoma.